The body does not age randomly. It follows a sequence of measurable biological events — mitochondrial decline, NAD+ depletion, hormonal dysregulation, cellular senescence, and systemic inflammation — each of which can be identified, tracked, and in many cases, meaningfully slowed.
Dr. GolBerg's IV therapy program is built on this premise. Each infusion protocol is selected following clinical assessment, not patient preference alone. Compounds, concentrations, infusion duration, and frequency are determined by biomarkers, health history, and long-term physiological objectives.
Intravenous delivery is the mechanism that makes precision longevity medicine possible at the cellular level. By bypassing the gastrointestinal tract entirely, therapeutic compounds reach systemic circulation at concentrations that oral supplementation cannot reliably achieve. This is the clinical distinction between a longevity protocol and a wellness trend.